|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of C4 Therapeutics (NASDAQ: CCCC) through any online brokerage.
The latest price target for C4 Therapeutics (NASDAQ: CCCC) was reported by B of A Securities on November 23, 2021. The analyst firm set a price target for 54.00 expecting CCCC to rise to within 12 months (a possible 54.97% upside). 6 analyst firms have reported ratings in the last year.
The stock price for C4 Therapeutics (NASDAQ: CCCC) is $34.845 last updated Today at 3:37:28 PM.
There are no upcoming dividends for C4 Therapeutics.
C4 Therapeutics’s $Q3 earnings are confirmed for after-market on November 10, 2021.
There is no upcoming split for C4 Therapeutics.
C4 Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.